NCT00266344View on ClinicalTrials.gov

MK0928 Study in Adult Patients With Primary Insomnia (0928-040)(COMPLETED)

PHASE2CompletedINTERVENTIONAL
Enrollment

520

Participants

Timeline

Start Date

November 30, 2005

Study Completion Date

October 31, 2006

Conditions
Primary Insomnia
Interventions
DRUG

MK0928, gaboxadol / Duration of Treatment 3 Weeks

DRUG

Placebo / Duration of Treatment 3 Weeks

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT00266344 - MK0928 Study in Adult Patients With Primary Insomnia (0928-040)(COMPLETED) | Biotech Hunter | Biotech Hunter